Walker-256 (LLC-WRC 256) Cells

The Walker-256 cell line is a rat carcinoma cell line that is widely used in cancer research, specifically in the study of tumor biology and chemotherapy. Originating from a mammary gland carcinoma of a rat, this cell line is particularly noted for its aggressive metastatic behavior, making it a valuable model for studying cancer progression and metastasis. It has been used extensively to investigate the mechanisms of tumor growth and the efficacy of anti-cancer drugs in vivo. Walker-256 cells are adaptable to various environments, allowing them to be grown in a number of different animal models, which helps in the study of cancer biology in a systemic context. This cell line is instrumental in pharmacological studies, particularly those related to the development and testing of new chemotherapy agents. Researchers use Walker-256 to assess drug-induced cytotoxicity and to explore the potential mechanisms of action of novel therapeutic compounds. Its robust use in research provides critical insights into the dynamics of tumor growth and the systemic effects of tumors on host physiology. Rat cell lines, Mammary gland, Adenocarcinoma of the rat mammary gland, Growth Conditions: Suspension, Biosafety level: BSL 1